Healthtech Startups

Daymark provides 24/7 in-home and virtual cancer care, offering patients an oncology-specialized team available by phone, text, video, or home visits to coordinate testing, manage symptoms and medications, and handle care logistics. It works through patients' health insurance and partners with insurance providers, serving cancer patients, families, and their care teams.

4 investors

DeepEcho develops AI-powered intelligent ultrasound technology to detect birth defects, preterm birth, and low birth weight in newborns. The solution uses deep learning algorithms to help reduce preventable child mortality.

4 investors

DeepCure uses AI and machine learning to accelerate drug discovery and development for treating diseases. The company combines computational biology with experimental validation to identify and optimize therapeutic candidates.

4 investors

Delta Development Team manufactures temperature-controlled medical transport and storage devices, including smart blood coolers and autonomous refrigeration units, for healthcare facilities and blood banks.

4 investors

DEO.care builds an AI-backed digital twin of the operating room, collecting OR activity data to provide analytics, benchmarking, and predictive workflow modeling for hospitals, surgeons, and healthcare industry leaders. The health tech company serves surgical teams across Europe and the U.S. to increase surgery volume, reduce team fatigue, and lower the cost of surgery.

4 investors

Develo builds pediatric practice management software that goes beyond a traditional EMR, handling scheduling, clinical charting, billing, and family engagement for independent pediatric practices. Its FHIR-native platform uses a family-centered data architecture to support adolescent confidentiality and integrations with text, e-fax, e-prescribe, e-lab, payer, and vaccine registry systems.

4 investors

Devicare sells nutritional and health products, including supplements and monitoring devices for conditions such as kidney stones and urinary infections. The company serves consumers seeking health management solutions.

4 investors

Diffuse designs proteins using AI models trained on experimental data collected through proprietary assays and software, delivering validated AI-designed proteins to partners.

4 investors

Digital Diagnostics is a healthcare technology company that builds AI systems to diagnose disease by analyzing medical images. Its flagship system diagnoses diabetes-related eye disease at the point of care without requiring a physician to review the images, serving primary and specialty care providers.

4 investors

Digma Medical develops the Endoscopic Gastrointestinal Ablation Device (EGAD), a minimally invasive therapy using a console and single-use catheter for contactless, imaging-guided ablation of esophageal mucosal tissue, initially targeting Barrett's Esophagus. The device is designed for use in standard GI endoscopy suites and serves gastroenterology clinicians treating pre-cancerous and other GI pathologies.

4 investors

DiscureMD is developing a treatment focused on disc degeneration, a leading cause of back pain that affects most adults during their lifetime.

4 investors

Distalmotion develops DEXTER, a surgical robotics system for minimally invasive procedures such as hernia repair, cholecystectomy, and hysterectomy, used by surgeons and clinical teams. Founded as a spin-off from EPFL's Robotics Lab, the company serves the medical device and robotic surgery market in Europe and the United States.

4 investors

DiveThru provides mental health support through in-person studios and an online platform, offering therapy and psychological assessments. The company serves individuals seeking mental health care with an emphasis on accessibility and personalized matching with clinicians.

4 investors

dNovo develops direct reprogramming technology to convert skin, blood, or fat cells into new stem cells, targeting age-related stem cell depletion. The company aims to address aging through cellular regeneration for consumers.

4 investors

Dopl develops a software platform that enables specialists to remotely operate medical devices, beginning with telerobotic ultrasound to deliver diagnostic care to underserved communities. The company targets healthcare access disparities through remote robotic and autonomous care delivery.

4 investors

Droplette develops a delivery system that converts active skincare and clinical ingredients into a barrier-penetrating mist for application to the skin. Founded by MIT-trained scientists, the company's technology originated from research on epidermolysis bullosa, a rare genetic skin condition, and was adapted for skincare.

4 investors

Dutch is a virtual veterinary service that connects pet owners with licensed veterinarians for telemedicine consultations, prescriptions, and ongoing care for acute, chronic, and preventive pet health needs. It operates nationwide in the US, serving pet parents seeking more affordable and accessible vet care.

4 investors

DynamiCare offers a digital recovery platform that uses behavioral science and technology to help individuals reduce or eliminate their use of alcohol, drugs, and tobacco. The product focuses on addiction recovery and substance use treatment.

4 investors

Ease Health builds an AI-native electronic health record system designed for behavioral health practices that integrates CRM, EHR, and revenue cycle management into a single platform. The system targets behavioral health clinics and practices seeking to reduce administrative burden and improve operational efficiency.

4 investors

EBAMed develops non-invasive cardiac ablation technology using particle/proton beam therapy to treat cardiac arrhythmias, with in-house R&D focused on medical devices and cardiac software. It serves the cardiology and electrophysiology field, targeting patient treatment backed by clinical evidence.

4 investors

ecton develops financial technology focused on healthcare payments and patient loyalty, aiming to help patients manage medical costs and improve their financial health. It serves healthcare providers and the patients they treat in the United States.

4 investors

Eddii provides digital health tools for managing endocrine conditions, particularly Type-1 diabetes, combining daily disease management with specialist appointment scheduling. The platform serves patients seeking personalized endocrine care and better health outcomes.

4 investors

Edifice Health offers the Inflammatory Age test, a biomarker composite scoring system that measures and monitors a person's inflammatory and immune health for early detection and prevention of chronic disease. The test, derived from Stanford University research using omics platforms and AI, is provided to clinics, physicians, and healthcare providers to help manage patients' chronic inflammation and longevity.

4 investors

Edity develops an AI-powered platform that engineers therapeutic proteins and uses immune cells (such as T-cells and NK cells) as carriers to deliver them to diseased tissues. Its plug-and-play technology is compatible with allogeneic approaches and aimed at creating new modalities for intracellular therapy.

4 investors